Investing in a large facility for a single product is not always a sustainable business model. Collaborating with a CDMO can augment your capacity and expertise, refine your processes, and ultimately shorten your time to market.
This ebook will help you determine if working with a CDMO is right for you – and if so, you’ll discover the best practices that make working with a CDMO as efficient as possible.
To prevent delays and costly issues during molecular development, it is important to understand potential mechanisms of increased absorption with lipid formulations and the appropriate screening tools.
This presentation highlights how innovative protein analysis technologies have been adopted for better comparability, release testing, and impurity monitoring to improve characterization and productivity.
The Business Of Biotech’s Cell & Gene Miniseries opens with Dr. Carsten Brunn, President & CEO of Selecta Biosciences. Guest host Erin Harris joins our discussion on Selecta's ImmTOR platform and how the company is addressing the immunogenicity of AAV vectors challenge faced by gene therapy companies. Listen now and subscribe so you never miss an episode.